Nanoparticle Mediated Ultrasound Therapy and Diagnostic Imaging

• US 20080045865A1
• Filed: 11/13/2005
• Published: 02/21/2008
• Est. Priority Date: 11/12/2004
• Status: Abandoned Application

• Current Assignee: Hanoch Kislev
• Original Assignee: Hanoch Kislev
• Inventors: Kislev, Hanoch
• Application Number:
  US11/718,778
• Publication Number:
  US 20080045865A1
• Time in Patent Office: Days
• US Class Current: 601/3
• CPC Class Codes: A61B 18/28 for heating a thermal probe or absorber
• CPC Class Codes: A61B 5/0059 using light, e.g. diagnosis by transillumination, diascopy, fluorescence A61B5/0093, A61B5/1455, A61B5/02416 and A61B5/0261 take precedence
• CPC Class Codes: A61B 5/411 Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
• CPC Class Codes: A61B 5/415 the glands, e.g. tonsils, adenoids or thymus
• CPC Class Codes: A61B 5/418 lymph vessels, ducts or nodes
• CPC Class Codes: A61B 8/4444 related to the probe
• CPC Class Codes: A61B 8/481 involving the use of contrast agent, e.g. microbubbles introduced into the bloodstream analysis of echo signal exploiting properties of a contrast enhancer in devices for short-range imaging with acoustic waves G01S7/52039
• CPC Class Codes: A61N 2007/0039 using microbubbles
• CPC Class Codes: A61N 7/00 Ultrasound therapy lithotripsy A61B17/22, A61B17/225; massage using supersonic vibration A61H23/00 ; using ultrasound for introducing media into the body A61M37/0092
• CPC Class Codes: A61N 7/022 intracavitary

Abstract

The present invention relates to systems and methods for localized delivery of heat, useful for localized imaging and treatment of a biological material. The systems and methods of the invention can be utilized for localized treatment of cancer, inflammation or other disorders involving over proliferation of tissue, and for tissue repair. The method comprises exposing nanoparticles to electromagnetic radiation under conditions wherein the nanoparticles generate microbubbles which emit heat when exposed to ultrasonic radiation.

Claims

1-73. -73. (canceled)

74. A system for localized delivery of heat to a cell or a tissue preloaded with nanoparticles comprising:

a. an electromagnetic radiation source configured to irradiate the nanoparticles to induce the production of microbubbles by said nanoparticles;

b. a therapeutic ultrasonic wave generating source configured to irradiate the microbubbles as to induce heat production by said microbubbles; and

c. driving means coupled to the therapeutic ultrasonic wave generating source for driving said therapeutic ultrasonic source with a drive signal to generate therapeutic ultrasonic waves.

75. The system according to claim 74, further comprising a light guide coupled to the electromagnetic radiation source to target the electromagnetic radiation to the cell or tissue.

76. The system according to claim 74, further comprising a focusing apparatus coupled to the therapeutic ultrasonic wave generating source.

77. The system according to claim 74, wherein the photothermal cross-section of the preloaded nanoparticles is enhanced to at least the physical cross-section of said nanoparticles.

78. The system according to claim 74, wherein the preloaded nanoparticles are present at a concentration in the range selected from the group consisting of 10⁵ to 10⁹ nanoparticles/cm³ and 3*10⁵ to 3*10⁷ nanoparticles/cm³.

79. The system according to claim 74, wherein the electromagnetic radiation source is selected from the group consisting of a plurality of light emitting diode (LED) lamp, gaseous flash lamp, diode laser pumped flash lamp, solid-state laser, diode laser, and a gaseous laser.

80. The system according to claim 74, wherein the electromagnetic radiation source provides radiation selected from the group consisting of ultraviolet radiation, visible radiation and infrared radiation.

81. The system according to claim 80, wherein the electromagnetic radiation is infrared radiation in the range of from about 800 nm to about 1300 nm.

82. The system according to claim 74, wherein the electromagnetic radiation source provides radiation in a repetitive pulse mode wherein the pulse width is in the range of from 0.01 μ

sec to 10 μ

sec.

83. The system according to claim 74, wherein the therapeutic ultrasonic source comprises a housing, wherein the housing comprises at least one piezoelectric transducer element made of a material selected from the group consisting of quartz, barium titanate, lead zirconium titanate and poly(vinylidene fluoride).

84. The system according to claim 74, wherein the therapeutic ultrasonic source provides ultrasound radiation selected from the group consisting of continuous wave mode, pulsed wave mode and modulated wave mode.

85. The system according to claim 84, wherein the pulsed wave mode has a pulse width in the range of from 1 microsecond to about 0.5 second and wherein the pulse is synchronized with the electromagnetic radiation pulse.

86. The system according to claim 74, wherein the therapeutic ultrasonic source provides ultrasound radiation in a frequency range of from about 0.5 MHz to about 7.5 MHz.

87. The system according to claim 74, wherein the therapeutic ultrasonic source provides ultrasound radiation in a peak power level in the range of from about 0.05 W/cm² to about 20 W/cm².

88. The system according to claim 74, wherein the therapeutic ultrasonic source provides ultrasound radiation in an average power level in the range of from about 0.125 W/cm² to about 3 W/cm².

89. The system according to claim 74, wherein the driving means comprises radio-frequency (RF) signal generator, and further comprises an amplifier that amplifies the RF signal to produce a drive signal.

90. A method for inducing localized delivery of heat to a cell or a tissue comprising:

a. administering a plurality of nanoparticles to the cell or tissue;

b. irradiating the nanoparticles administered to said cell or tissue by electromagnetic radiation, as to induce the production of microbubbles; and

c. exposing the microbubbles of step (b) to ultrasound radiation;

wherein said microbubbles emit heat upon exposure to the ultrasound radiation.

91. The method according to claim 90, wherein the nanoparticle concentration is in the range selected from the group consisting of 10⁵ to 10⁹ nanoparticles/cm³ and 3*10⁵ to 3*10⁷ nanoparticles/cm³.

92. The method according to claim 90, wherein the nanoparticles are selected from the group consisting of nanoparticles comprising a metal component selected from the group consisting of gold, silver, copper, platinum, palladium, lead, and iron and non-metallic nanoparticles.

93. The method according to claim 92, wherein the non-metallic nanoparticles are carbon nanoparticles.

94. The method according to claim 90, wherein photothermal cross-section of the nanoparticles is enhanced to at least the physical cross-section of said nanoparticles.

95. The method according to claim 90, wherein the nanoparticles are coated with a material which enhances said nanoparticle tendency to form clusters or agglomerates following exposure to an external stimulus selected from the group consisting of electromagnetic radiation, ultrasound radiation shock wave or any combination thereof.

96. The method according to claim 90, wherein the nanoparticles are coated with a material which prevents said nanoparticles from forming clusters, wherein the material is neutralized following exposure to an external stimulus.

97. The method according to claim 96, wherein the external stimulus is provided by administering complementary nanoparticles to the cell or tissue wherein the complementary nanoparticles are designed to neutralize the coating material.

98. The method according to claim 90, wherein the nanoparticles are coupled to at least one type of molecules, wherein the molecules specifically bind to the cell or tissue.

99. The method according to claim 98, wherein the binding is by formation of an antigen-antibody complex or by formation of a ligand-receptor complex.

100. The method according to claim 90, wherein the nanoparticle diameter is in the range of from about 10 to about 1,000 nanometer.

101. The method according to claim 90, wherein the nanoparticles have an external shape selected from the group consisting of spherical shape, cubic shape, oval shape and rod shape.

102. The method according to claim 90, wherein the nanoparticle structure is selected from the group consisting of solid structure, core/shell structure, hollow structure, tubular structure and star-like structure.

103. The method according to claim 90, wherein the electromagnetic radiation is selected from the group consisting of ultraviolet radiation, visible radiation and infrared radiation.

104. The method according to claim 103, wherein the infrared radiation is in the range of from about 800 nm to about 1300 nm.

105. The method according to claim 90, wherein the electromagnetic radiation is administered in a repetitive pulse mode, wherein the pulse width is in the range of from 0.01 μ

sec to 10 μ

sec.

106. The method according to claim 90, wherein the ultrasound radiation is applied in a mode selected from a continuous wave mode and a pulsed wave mode.

107. The method according to claim 106, wherein the pulse width is in the range of from 1 microsecond to about 0.5 second.

108. The method according to claim 90, wherein the ultrasound radiation frequency is in the range of from about 0.5 MHz to about 7.5 MHz.

109. The method according to claim 90, wherein the ultrasound radiation peak power level is in the range of from about 0.05 W/cm² to about 20 W/cm².

110. The method according to claim 90, wherein the ultrasound radiation average power level is in the range of from about 0.125 W/cm² to about 3 W/cm².

111. The method according to claim 90, wherein the electromagnetic radiation is applied through a light guide, wherein the light guide is located adjacent to the cell or tissue.

112. The method according to claim 90, wherein the microbubbles are exposed to the ultrasound radiation through an insertable applicator, wherein the tip of the applicator is located adjacent to the cell or tissue.

113. The method according to claim 90, further comprising the step of exposing the cell or tissue to electric field optimized to cause sensitization of said cell or tissue prior to nanoparticle irradiation with the electromagnetic radiation.

114. The method according to claim 90, for treating a tumor cell or tissue selected from the group consisting of malignant and non-malignant tumor cell or tissue.

115. The method according to claim 114, wherein the method is applied in combination with additional anti-tumor therapy.

116. The method according to claim 90, for dissolving a blood clot.

117. The method according to claim 90, for reducing the size of or removing at least one stone from a kidney.

118. The method according to claim 90, for treating inflammation in a cell or a tissue.

119. The method according to claim 90, for joining a tissue.

120. The method according to claim 119, wherein the tissue is joined to another tissue.

121. The method according to claim 119, wherein the tissue is joined to a non-tissue material.

122. The method according to claim 90, for a cosmetic treatment of targeted skin regions selected from the group consisting of treating vascular lesions, pigmented lesions, acne and unsightly skin formation;

removing unwanted hair; and

reducing stretch marks or wrinkles.

123. An ultrasonic imaging system for diagnosing a cell or a tissue preloaded with nanoparticles comprising:

a. an electromagnetic radiation source configured to irradiate the nanoparticles to induce the production of microbubbles by said nanoparticles;

b. at least one imaging ultrasonic wave generating source configured to irradiate the microbubbles as to enhance the ultrasound imaging contrast of said cell or tissue administered with said nanoparticles;

an ultrasound probe;

c. driving means coupled to the imaging ultrasonic wave generating source for driving said imaging ultrasonic source with a drive signal to generate imaging ultrasonic waves; and

d. an ultrasound probe.

124. The system according to claim 123, further comprising a light guide coupled to the electromagnetic radiation source to target the electromagnetic radiation to the cell or tissue.

125. The system according to claim 123, further comprising a focusing apparatus coupled to the imaging ultrasonic source.

126. The system according to claim 123, wherein the photothermal cross-section of the preloaded nanoparticles is enhanced to at least the physical cross-section of said nanoparticles.

127. The system according to claim 123, wherein the preloaded nanoparticles are present in a concentration in the range selected from the group consisting of 10⁵ to 10⁹ nanoparticles/cm³ and 3*10⁵ to 3*10⁷ nanoparticles/cm³.

128. The system according to claim 123, wherein the electromagnetic radiation source provides radiation selected from the group consisting of visible radiation and infrared radiation.

129. The system according to claim 128, wherein the electromagnetic radiation is infrared radiation in the range of from about 800 nm to about 1300 nm.

130. The system according to claim 123, wherein the electromagnetic radiation source provides radiation in a repetitive pulse mode, wherein the pulse width is in the range of from 0.01 μ

sec to 10 μ

sec.

131. The system according to claim 123, wherein the imaging ultrasonic source emission mode is selected from the group consisting of short pulse trains and Contrast Pulse Sequencing (CPS).

132. The system according to claim 123, wherein the driving means and the imaging ultrasonic source are configured for two-dimensional ultrasound imaging in a B-mode.

133. A method for ultrasonic imaging of a cell or a tissue, comprising:

a. administering nanoparticles to the cell or tissue;

b. irradiating the nanoparticles administered to said cell or tissue by electromagnetic radiation, as to induce the production of microbubbles; and

c. exposing the microbubbles of step (b) to ultrasound radiation;

wherein said microbubbles enhance the ultrasound imaging contrast of said cell or tissue administered with said nanoparticles.

134. The method according to claim 133 for diagnosing a diseased cell or tissue surrounded by healthy cells or tissue.

135. The method according to claim 133 for imaging a cell or tissue during a therapeutic treatment.